- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT01934413
Technology-enhanced Transitional Care for Rural Palliative Care Patients: A Pilot Study (TPC)
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
The purpose of the proposed research is to design and evaluate a technology enhanced transitional palliative care (TPC) intervention for patients living in rural locations. The contributions of the proposed research are expected to address the gap in palliative care services and transitions of care for rural patients. This research is significant because it addresses the challenges of three independently important health care foci - needs of rural patients, care transitions, and the evolving field of palliative care. The study will not simply address the critical barrier imposed by distance, but also extend PC practice by improving transition management for the impending dramatic increase in seriously ill and dying patients in rural areas through evolving demographic shifts. The goal of the proposed research is to advance the development of transitional care strategies for rural PC patients and caregivers, and provide evidence of new ways to support continuity of care for patients with life-limiting conditions.
The study is guided by the "Transitional Care Model" or "TCM" as developed by Naylor which combines quality, cost, and satisfaction. The TCM has a solid evidence base from more than 15 years of multidisciplinary research. Unique features of the model include care that is delivered and coordinated by the same nurse across hospital and home settings 7 days per week for an average of 2 to 3 months using evidence-based protocols with a focus on long term outcomes. Core components of the model include a holistic, person/family centered approach and protocol guided care. The nurse functions as part of an interdisciplinary team with shared accountability, however, the nurse is the single "point person" across an episode of care providing the vital link from hospital to home. Inherent within the model is shared communication systems that span care settings.
A randomized control trial design will be used. Community dwelling adult patients and their caregivers who receive a palliative care consult while hospitalized in the hospital will be enrolled in the study, then randomized to group membership and followed for a total of 8 weeks after hospital discharge. Following a detailed protocol for TPC, the intervention group will receive weekly video session visits (using computer software that allows audio/visual contact through the computer screen) by the study nurse. The investigators will determine the feasibility and acceptability of the TPC intervention and study methods and procedures when engaging palliative care patients and their caregivers. The investigators will compare patient and caregiver reported outcomes and determine effect size for patients receiving technology-enhanced TPC (intervention group) to patients in the control group, and they will explore the impact of the technology-enhanced TPC intervention on health care service utilization.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Minnesota
-
Mankato, Minnesota, Forenede Stater, 56001
- Mayo Health System
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Barn
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Adult patients hospitalized at study site, and their designated caregiver (if available)
- Receiving palliative care
- Returning home or to a facility for short term (30 days) rehabilitation
- Able to provide informed consent
- Able to complete self-reported questionnaires without assistance
Exclusion Criteria:
- Long-term placement in skilled nursing facility after hospitalization
- Receiving hospice
- Living within city limits of hospital
- Cognitive impairments
- Non-English speaking
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Støttende pleje
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Aktiv komparator: Technology-Enhanced TPC
In addition to receiving usual palliative care service in the hospital setting, Technology-Enhanced Transitional Palliative Care patients will receive Transitional Care from the Palliative Care consulting team beginning in the hospital within 24 hours of study enrollment and continuing post discharge for eight weeks in their homes in rural locations by means of video visits with the Palliative Care consulting team.
|
The Transitional Care intervention will be initiated within 24 hours after enrollment, and will include initial transitional care planning, daily hospital visits, crisis prevention planning by an experienced Palliative Care nurse.
The intervention will continue after the patient is discharged to home or short term skilled nursing facility, and it will involve an in-person visit between 24-48 hours post discharge, weekly virtual visits via iPad and video conference technology, and additional home visits as needed.
Care plans established during initial planning will be implemented and adjusted under the guidance of the palliative care nurse delivering the intervention.
|
Andet: Usual standard of care
The control group will receive only the current standard palliative care service in the hospital setting, which includes standard in-hospital palliative care consultation and standard discharge planning.
|
Usual care includes routine hospital discharge planning and usual physician care in primary and specialty outpatient clinics post hospital discharge.
The PC consulting service provides consulting services in the inpatient setting.
There are no standardized, intentional services provided to outpatients by the PC consulting team.
Services provided to outpatients may occur sporadically as initiated by the patient.
The majority of PC follow-up if any is a single phone call to the patient/caregiver.
To account for the time spent and number of contacts made with the intervention group, the control group will be contacted by phone weekly by a non-nurse member of the study team not involved with the intervention, asked to relate what, if any, medically-related events occurred.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Change in mean scores on FACIT-Pal Questionnaire
Tidsramme: Baseline, 1 month post-enrollment, 2 months post-enrollment
|
The patient's quality of life will be determined by the change in mean scores from baseline to 1 month and 2 months post enrollment, using the Functional Assessment of Chronic Illness Therapy - Palliative Care Scale (FACIT-Pal).
The FACIT-Pal palliative subscale contains 19 questions specific to persons with life-limiting illness.
Each item is rated on a 5 point numeric rating scale from 9 (not at all) to 4 (very much).
Scores range from 0-76.
Higher scores indicate better quality of life.
|
Baseline, 1 month post-enrollment, 2 months post-enrollment
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Change in mean scores on ESAS-r Questionnaire
Tidsramme: Baseline, 1 month post-enrollment, 2 months post-enrollment
|
The patient's symptom intensity will be determined by the change in mean scores from baseline to 1 month and 2 months post enrollment, as measured by the Edmonton Symptom Assessment System (revised) ESAS-r scale, The ESAS-r captures the patient's perspective on 9 symptoms that are common in palliative care (pain, tiredness, drowsiness, nausea, lack of appetite, shortness of breath, depression, anxiety, wellbeing).
An optional 10th symptom can be reported.
Each symptom is rated on an 11 point numeric rating scale from 0 (symptom absent or best) to 10 (worst possible).
Scores range from 0-100, with lower scores indicating patient perceives fewer or no symptoms and higher scores indicating patient perceives worse symptoms.
|
Baseline, 1 month post-enrollment, 2 months post-enrollment
|
Andre resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Health Care Service Utilization
Tidsramme: Baseline to 6 months after enrollment
|
Health Services information will be summarized by review of medical records and administrative databases for number of unplanned hospitalizations, number of intensive care unit days, total length of hospital stay (days), number of emergency department visits, number of clinic office visits, number of home healthcare visits, time (in days) to hospice admission, and time (days) receiving hospice.
|
Baseline to 6 months after enrollment
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Diane E Holland, PhD, RN, Mayo Clinic
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- 13-006242
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Palliativ pleje
-
Azienda Usl di BolognaIRCCS Azienda Ospedaliero-Universitaria di BolognaAfsluttetPalliativ pleje | Palliativ medicin | Hospice og palliativ sygeplejeItalien
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRekrutteringCAR-T Terapi KomplikationerItalien
-
Stiftung Swiss Tumor InstituteKlinik Hirslanden, Zurich; Palleos Healthcare GmbHRekrutteringPatientrapporterede resultatmål | CAR T-celleterapiSchweiz
-
The Lymphoma Academic Research OrganisationNovartis; Gilead SciencesRekrutteringHæmatopatologi kvalificeret eller CAR-t-cellebehandlingFrankrig
-
Henan Cancer HospitalFundamenta Therapeutics, Ltd.Ikke rekrutterer endnuAllogen, CAR-T, proteinsekvestrering, ikke-genredigeretKina
-
Ankara Yildirim Beyazıt UniversityRekruttering
-
Radboud University Medical CenterKU Leuven; University Hospital, Bonn; Clinica Universidad de Navarra, Universidad... og andre samarbejdspartnereRekrutteringPalliativ SedationTyskland, Holland, Belgien, Italien, Spanien
-
University Hospital, CaenRekruttering
-
Charite University, Berlin, GermanyKing's College Hospital NHS Trust; National and Kapodistrian University... og andre samarbejdspartnereTrukket tilbage
-
University of PennsylvaniaNational Institute on Aging (NIA)Tilmelding efter invitationPalliativ plejeForenede Stater
Kliniske forsøg med Technology-Enhanced Transitional Palliative Care
-
The Hong Kong Polytechnic UniversityHospital Authority, Hong KongAfsluttetPalliativ pleje | Nyresvigt, slutstadieHong Kong
-
University of North Carolina, CharlotteNational Heart, Lung, and Blood Institute (NHLBI)AfsluttetUkontrolleret hypertensionForenede Stater
-
Brown UniversityNational Institute on Drug Abuse (NIDA); University of Washington; UConn... og andre samarbejdspartnereAktiv, ikke rekrutterendeOpioidbrugsforstyrrelseForenede Stater